NCT06882096View on ClinicalTrials.gov

Tracing the Metabolic Flux of Orally Administered NAD+ Precursors

PHASE1RecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 28, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions
Healthy Adults
Interventions
DRUG

Nicotinamide Mononucleotide (NMN)

Nicotinamide Mononucleotide (NMN)

DRUG

Nicotinamide (NAM)

Nicotinamide (NAM)

Trial Locations (1)

02215

RECRUITING

Brigham and Women's Hospital, Boston

Sponsors
All Listed Sponsors
lead

Metro International Biotech, LLC

INDUSTRY